A Clinical-stage biopharmaceutical company, Onconova Therapeutics, Inc. (NASDAQ: ONTX) is developing novel therapeutics to combat cancer. The Company is developing a pipeline of small molecule candidates that target various forms of cancers such as Solid Tumors and KRAS+ NSCLC and a RAS pathway and a...
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering with bringing their clinical candidates to fruition. While Vaccine development and therapeutics to combat the COVID-19 pandemic are at the forefront of development activities in the biotech sector,...
A clinical-stage company Minerva Neurosciences, Inc. (NASDAQ: NERV) is developing an array of products for treating Central Nervous System (CNS) disorders, this biopharmaceutical company aims to deliver innovative solutions by harnessing the potential of serotonin receptors to combat disorders such as Schizophrenia and Parkinson’s disease. The...
Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer of leading-edge implantable visual prosthetics, announced the results from a two-year study evaluating the feasibility of the Orion Visual Cortical Prosthesis (Orion). The Orion® Visual Cortical Prosthesis System is a next-generation device that provides artificial vision to...
Heron Therapeutics, Inc. (NASDAQ: HRTX) has a major upcoming catalyst in the form of the upcoming Prescription Drug User Fee Act (PDUFA) date for FDA approval on May 12, 2021 for HDX-011 (Zynrelef). HTX-011 is an extended-release, dual-acting local anesthetic that uses a combination of...
Heska Corporation (NASDAQ: HSKA) is a premier veterinary diagnostic and specialty products manufacturer with presence in major markets such as the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The Company aims to bring leading-edge healthcare solutions to pets, through innovation...
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering with bringing their clinical candidates to fruition. While Vaccine development and therapeutics to combat the COVID-19 pandemic are at the forefront of development activities in the biotech sector,...
Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) has been having a fantastic run at the stock market this year, with its shares rising by almost 1800 percent since the stock began trading in March 2021. The stock has caught the attention of reddit traders as a low...
The Company is developing a pipeline of candidates focused on small molecules and biologics that can treat central nervous system (CNS) and immunology disorders. Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) lead candidate for CNS is TNX-102 SL (sublingual formulation of cyclobenzaprine), a non-opioid, centrally-acting analgesic...
Evelo Biosciences, Inc. (NASDAQ: EVLO) is focused on developing innovative oral biologics that target cells in the intestines for the treatment of a range of inflammatory diseases and cancer. The Company’s approach is to develop systemically acting biologics that can act on the cells in...
